Lance Berberian V.'s Insider Trades & SAST Disclosures
Lance Berberian V.'s most recent trade in Laboratory Corp. Of America Holdings was a trade of 323 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lance Berberian V..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 16,766 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 1,067 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 86 | 16,680 (0%) | 0% | 245.1 | 21,082 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 356 | 16,277 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 356 | 1,744 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 1,390 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 16,537 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 94 | 16,183 (0%) | 0% | 247.7 | 23,288 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 94 | 16,443 (0%) | 0% | 246.3 | 23,149 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Sale of securities on an exchange or to another person at price $ 228.95 per share. | 05 Aug 2024 | 9,848 | 15,921 (0%) | 0% | 228.9 | 2,254,685 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Sale of securities on an exchange or to another person at price $ 229.78 per share. | 05 Aug 2024 | 2,245 | 25,769 (0%) | 0% | 229.8 | 515,867 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 7,697 | 2,100 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 7,697 | 31,313 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 3,299 | 28,014 (0%) | 0% | 216.6 | 714,464 | Common Stock |
| Laboratory Corp. Of Americ... | Berberian V. Lance | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 23,703 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance Berberian V. | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 9,797 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Berberian Lance V. | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 87 | 23,616 (0%) | 0% | 227.4 | 19,788 | Common Stock |
| Laboratory Corp. Of Americ... | Lance Berberian V. | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 3,300 | 3,300 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Lance Berberian V. | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,070 | 10,474 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 23,473 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Berberian Lance V. | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 10,121 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | V. Berberian Lance | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 94 | 23,379 (0%) | 0% | 223.7 | 21,029 | Common Stock |
| Laboratory Corp. Of Americ... | Berberian V. Lance | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 331 | 23,209 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 331 | 9,404 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | V. Lance Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 89 | 23,120 (0%) | 0% | 221.5 | 19,717 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 7,758 | 9,585 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 4,509 | 24,677 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 1,799 | 22,878 (0%) | 0% | 224.7 | 404,235 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 1,827 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 20,253 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 85 | 20,168 (0%) | 0% | 248.1 | 21,091 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 3,000 | 3,000 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 950 | 2,117 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 374 | 20,071 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 374 | 1,167 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.50 per share. | 04 Feb 2023 | 108 | 19,963 (0%) | 0% | 244.5 | 26,406 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 297 | 19,799 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 297 | 1,541 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.99 per share. | 02 Feb 2023 | 102 | 19,697 (0%) | 0% | 255.0 | 26,009 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2022 | 5,310 | 21,862 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.42 per share. | 27 Mar 2022 | 2,360 | 19,502 (0%) | 0% | 276.4 | 652,351 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 3,100 | 3,100 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,354 | 16,997 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,354 | 2,192 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 870 | 4,546 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.68 per share. | 11 Feb 2022 | 694 | 16,657 (0%) | 0% | 272.7 | 189,240 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 354 | 17,351 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 354 | 1,838 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.68 per share. | 11 Feb 2022 | 105 | 16,552 (0%) | 0% | 272.7 | 28,631 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 373 | 14,752 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 373 | 3,676 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.48 per share. | 04 Feb 2022 | 109 | 14,643 (0%) | 0% | 277.5 | 30,245 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 296 | 14,482 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 296 | 4,049 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.18 per share. | 02 Feb 2022 | 103 | 14,379 (0%) | 0% | 273.2 | 28,138 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2021 | 2,413 | 15,265 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 251.58 per share. | 27 Mar 2021 | 1,079 | 14,186 (0%) | 0% | 251.6 | 271,455 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,353 | 4,698 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,353 | 13,303 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 699 | 12,604 (0%) | 0% | 238.3 | 166,544 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 353 | 12,957 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 353 | 4,345 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 234 | 7,051 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 234 | 11,019 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 105 | 12,852 (0%) | 0% | 238.3 | 25,017 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 69 | 10,950 (0%) | 0% | 238.3 | 16,440 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 373 | 10,916 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 373 | 7,285 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.78 per share. | 04 Feb 2021 | 131 | 10,785 (0%) | 0% | 223.8 | 29,315 | Common Stock |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 3,100 | 3,100 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 890 | 7,658 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2020 | 3,880 | 12,238 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.95 per share. | 30 Mar 2020 | 1,695 | 10,543 (0%) | 0% | 131.9 | 223,655 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges